Results

Total Results: 2,325 records

Showing results for "decision".

2201. Hepatic-Fibrosis White-Paper (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatic-fibrosis_white-paper.pdf
      April 01, 2014 - Research White Paper Impact of Contacting Study Authors on Systematic Review Conclusions: Diagnostic Tests for Hepatic Fibrosis Research White Paper Impact of Contacting Study Authors on Systematic Review Conclusions: Diagnostic Tests for Hepatic Fibrosis Prepared for: Agency for Healthcare Research an…

2202. Migraine-Prevention Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
      June 01, 2013 - 1 Comparative Effectiveness Review Number 108 Migraine in Children: Preventive Pharmacologic Treatments Executive Summary Introduction The Agency for Healthcare Research and Quality (AHRQ) commissioned the Minnesota Evidence-based Practice Center (EPC) to conduct a review of preventive pharmacologic treatm…

2203. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
      September 07, 2012 - Disposition of Comments for Progestogens for Prevention of Preterm Birth Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1239 Published Online: September 7, 2012 Comparative Effectiveness Research Review Disposition of Comments Report …

2204. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
      May 01, 2017 - As a 2012 SR by another EPC reviewed the effects of the physical interventions,7 we made the decision

2205. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-to
      June 17, 2009 - variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision

2206. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-differ
      January 20, 2011 - variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision

2207. What are the best practice Behavioral Health programs for type 1 diabetes, type 2 diabetes and gestational diabetes. Does educational counseling help paitients improve control and adherence to treatment? | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-are-the-best-practice-behavioral-health-programs-for-type-1-diabetes-type-2-diabetes-and-gestational-diabetes-does-educational-counseling-help-paitients-improve-control-and-adherence-to-treatment
      May 04, 2012 - variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision

2208. What is the comparative renal of differnt contrast media used in radiographic imaging ? What is the comparative efficacy of different therapies in preventing contrast induced nephropathy? | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-renal-of-differnt-contrast-media-used-in-radiographic-imaging-what-is-the-comparative-efficacy-of-different-therapies-in-preventing-contrast-induced-nephropathy
      December 30, 2011 - variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision

2209. Psoriasis-Chronic Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
      November 01, 2012 - 1 Comparative Effectiveness Review Number 85 Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis Executive Summary Background Psoriasis is a common, chronic, autoimmune inflammatory skin disease affecting 2 to 3 percent of the worldwide population. The onse…

2210. Diagnosis and Treatment of Localized Muscle Invasive Bladder Cancer | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-treatment-localized-muscle-invasive-bladder-cancer
      January 24, 2013 - variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision … Decision-making by urologists oftentimes is empirically-based, although more evidence is being published … treatment to recommend; a guideline such as that proposed for this evidence report would aid in the decision

2211. Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
      October 03, 2012 - variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision … Decision-making by urologist oftentimes is empirically-based, although more evidence is being published … treatment to recommend; a guideline such as that proposed for this evidence report would aid in the decision

2212. Wheeled Mobility (Wheelchair) Service Delivery (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/wheelchair-service_disposition-comments.pdf
      January 01, 2012 - Souza A, Kelleher A, Cooper R, Cooper RA, Iezzoni LI, components that may influence provider decision … Payors- What are the qualifications of the decision makers that make approval/denial decisions? … Do the decision makers apply professional judgment in the review process or rely solely on decision … We suggest asking the payors, “What are the qualifications of the decision makers that make approval … Given the complexity and uniqueness of each individual situation application of a decision tree or

2213. The Effect of Protein Intake on Health (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol-amendment.pdf
      November 29, 2023 - The Effect of Protein Intake on Health Evidence-based Practice Center Systematic Review Protocol Project Title: The Effect of Protein Intake on Health Publication Date: June 2, 2023 Amendment Date(s): November 17, 2023, November 28, 2023, November 29, 2023 (Amendments Details–see Section VI) I. Ba…

2214. Evaluation of Dietary Protein Intake Requirements (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
      November 28, 2023 - Evaluation of Dietary Protein Intake Requirements Evidence-Based Practice Center Systematic Review Protocol Project Title: Evaluation of Dietary Protein Intake Requirements Publication Date: June 2, 2023 Amendment Date(s): November 17, 2023, November 28, 2023 (Amendments Details–see Section VI) I. B…

2215. Methods Guide for Medical Test Reviews Chapter 9 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
      July 01, 2012 - Methods Guide for Medical Test Reviews Chapter 9 9-1 Chapter 9 Options for Summarizing Medical Test Performance in the Absence of a “Gold Standard” Thomas A. Trikalinos, M.D., Tufts Evidence-based Practice Center, Boston, MA Cynthia M. Balion, Ph.D., Hamilton General Hospital and McMaster Evidence-based…

2216. #14 SUBSTANCE ABUSE (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
      December 01, 2015 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahr…

2217. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
      January 01, 2007 - Layout 1 Background Aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone are atypical antipsychotics approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These drugs have been studied for off-label use in the following conditions: dementia and seve…

2218. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
      June 01, 2012 - This is a subjective decision without hard-and-fast rules.

2219. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
      June 01, 2012 - This is a subjective decision without hard-and-fast rules.

2220. Arteriovenous Malformations | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/arteriovenous-malformations